The Defense Logistics Agency (DLA) awarded a $4,681.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract, which does not have a set-aside designation, enables the DLA to issue delivery orders to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has a proven track record of providing pharmaceutical products and services to the Department of Defense through its federal contract awards.
Generated 2/17/25, 9:43 PM